SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-077910
Filing Date
2023-03-23
Accepted
2023-03-23 16:24:38
Documents
5
Effectiveness Date
2023-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 d481753ds8.htm S-8 39466
2 EX-5.1 d481753dex51.htm EX-5.1 5441
3 EX-23.1 d481753dex231.htm EX-23.1 1448
4 EX-FILING FEES d481753dexfilingfees.htm EX-FILING FEES 23062
5 GRAPHIC g481753g0320103049105.jpg GRAPHIC 3159
  Complete submission text file 0001193125-23-077910.txt   74925
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270788 | Film No.: 23756559
SIC: 2836 Biological Products, (No Diagnostic Substances)